NB Mercado, R Zahn, F Wegmann, C Loos… - Nature, 2020 - europepmc.org
A safe and effective vaccine for severe acute respiratory syndrome coronavirus 2 (SARS- CoV-2) may be required to end the coronavirus disease 2019 (COVID-19) pandemic 1–8 …
NB Mercado, R Zahn, F Wegmann, C Loos… - paper.sciencenet.cn
A safe and effective vaccine for severe acute respiratory syndrome coronavirus 2 (SARS- CoV-2) may be required to end the coronavirus disease 2019 (COVID-19) pandemic1–8 …
NB Mercado, R Zahn, F Wegmann, C Loos… - Nature, 2020 - ncbi.nlm.nih.gov
A safe and effective vaccine for severe acute respiratory syndrome coronavirus 2 (SARS- CoV-2) may be required to end the coronavirus disease 2019 (COVID-19) pandemic 1–8 …
NB Mercado, R Zahn, F Wegmann, C Loos… - Nature, 2020 - go.gale.com
A safe and effective vaccine for severe acute respiratory syndrome coronavirus 2 (SARS- CoV-2) may be required to end the coronavirus disease 2019 (COVID-19) pandemic. sup. 1 …
NB Mercado, R Zahn, F Wegmann, C Loos… - …, 2020 - pubmed.ncbi.nlm.nih.gov
A safe and effective vaccine for severe acute respiratory syndrome coronavirus 2 (SARS- CoV-2) may be required to end the coronavirus disease 2019 (COVID-19) pandemic 1-8 …
NB Mercado, R Zahn, F Wegmann, C Loos… - Nature, 2020 - cdr.lib.unc.edu
A safe and effective vaccine for severe acute respiratory syndrome coronavirus 2 (SARS- CoV-2) may be required to end the coronavirus disease 2019 (COVID-19) pandemic1–8 …
NB Mercado, R Zahn, F Wegmann, C Loos… - …, 2020 - ui.adsabs.harvard.edu
A safe and effective vaccine for severe acute respiratory syndrome coronavirus 2 (SARS- CoV-2) may be required to end the coronavirus disease 2019 (COVID-19) pandemic 1-8 …
NB Mercado, R Zahn, F Wegmann, C Loos… - Nature, 2020 - ideas.repec.org
A safe and effective vaccine for severe acute respiratory syndrome coronavirus 2 (SARS- CoV-2) may be required to end the coronavirus disease 2019 (COVID-19) pandemic1–8 …